Towards elucidating the connection between epithelial-mesenchymal transitions and stemness

Journal of the Royal Society Interface

Volumn 11, Issue 101, 2014, Pages

  Jolly, Mohit Kumar ^a,b   Huang, Bin ^a   Lu, Mingyang ^a   Mani, Sendurai A ^c   Levine, Herbert ^a,b   Ben Jacob, Eshel ^a,d  

^a RICE UNIVERSITY   (United States)

^b Rice University   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer stem cells; Epithelial mesenchymal transition; Hybrid epithelial mesenchymal phenotype; LIN28 let 7; Stemness

Indexed keywords

DISEASES;

CANCER STEM CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HYBRID EPITHELIAL/MESENCHYMAL PHENOTYPE; LIN28/LET-7; STEMNESS;

STEM CELLS;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 200; HOMEODOMAIN PROTEIN; LIN-28 PROTEIN, HUMAN; MICRORNA; MIRN200 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN; RNA; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; ZEB1 PROTEIN, HUMAN;

ARTICLE; CANCER STEM CELL; CONCEPTUAL FRAMEWORK; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; ONCOGENE C MYC; PHENOTYPE; WOUND HEALING; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY;

EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASTIC STEM CELLS; RNA, NEOPLASM; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 84922345421     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2014.0962     Document Type: Article

References (61)

1. Wan L, Pantel K, Kang Y. 2013 Tumor metastasis: moving new biological insights into the clinic. Nat. Med. 19, 1450-1464. (doi:10.1038/nm.3391)
2. May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA. 2011 Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 13, 202. (doi:10.1186/bcr2789)
3. Tsai JH, Yang J. 2013 Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192-2206. (doi:10.1101/gad.225334.113)
4. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. 2013 MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc. Natl Acad. Sci. USA 110, 18 144-18 149. (doi:10.1073/pnas.1318192110)
5. Huang RY-J et al. 2013 An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 4, e915. (doi:10.1038/cddis.2013.442)
6. Revenu C, Gilmour D. 2009 EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev. 19, 338-342. (doi:10.1016/j.gde.2009.04.007)
7. Yu M et al. 2013 Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 19, 349-361. (doi:10.1126/science.1228522)
8. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. 2011 Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105, 1338-1341. (doi:10.1038/bjc.2011.405)
9. Hou J-M et al. 2011 Circulating tumor cells as a window on metastasis biology in lung cancer. Am. J. Pathol. 178, 989-996. (doi:10.1016/j.ajpath.2010.12.003)
10. Armstrong AJ et al. 2011 Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9, 997-1007. (doi:10.1158/1541-7786.MCR-10-0490)
11. Bednarz-Knoll N, Alix-Panabières C, Pantel K. 2012 Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 31, 673-687. (doi:10.1007/s10555-012-9370-z)
12. Mani SA et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715. (doi:10.1016/j.cell.2008.03.027)
13. Morel A-P, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. 2008 Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3, e2888. (doi:10.1371/journal.pone.0002888)
14. Yang X et al. 2010 Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res. 70, 9463-9472. (doi:10.1158/0008-5472.CAN-10-2388)
15. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. 2010 Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 5, e12445. (doi:10.1371/journal.pone.0012445)
16. Qiu C, Ma Y, Wang J, Peng S, Huang Y. 2010 Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res. 38, 1240-1248. (doi:10.1093/nar/gkp1071)
17. Wang G et al. 2013 Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to- epithelial transition and induced pluripotent stem cell generation. Proc. Natl Acad. Sci. USA 110, 2858-2863. (doi:10.1073/pnas.1212769110)
18. Niwa H, Miyazaki J, Smith AG. 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376. (doi:10.1038/74199)
19. Karwacki-Neisius V et al. 2013 Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell 12, 531-545. (doi:10.1016/j.stem.2013.04.023)
20. Theunissen TW, van Oosten AL, Castelo-Branco G, Hall J, Smith A, Silva JCR. 2011 Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr. Biol. 21, 65-71. (doi:10.1016/j.cub.2010.11.074)
21. Chang T-C et al. 2009 Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl Acad. Sci. USA 106, 3384-3389. (doi:10.1073/pnas.0808300106)
22. Wang Z et al. 2011 C-myc inhibits the transcription of the microRNA cluster MC-let-7a-1∼let-7d via a non-canonical E-box. J. Biol. Chem. 286, 39 703-39 714. (doi:10.1074/jbc.M111.293126)
23. Iliopoulos D, Hirsch HA, Struhl K. 2009 An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706. (doi:10.1016/j.cell.2009.10.014)
24. Wang DJ, Legesse-Miller A, Johnson EL, Coller HA. 2012 Regulation of the let-7a-3 promoter by NF-κB. PLoS ONE 7, e31240. (doi:10.1371/journal.pone.0031240)
25. Macía J, Widder S, Solé R. 2009 Why are cellular switches Boolean? General conditions for multistable genetic circuits. J. Theor. Biol. 261, 126-135. (doi:10.1016/j.jtbi.2009.07.019)
26. Andrecut M, Halley JD, Winkler DA, Huang S. 2011 A general model for binary cell fate decision gene circuits with degeneracy: indeterminacy and switch behavior in the absence of cooperativity. PLoS ONE 6, e19358. (doi:10.1371/journal.pone.0019358)
27. Huang S, Guo Y-P, May G, Enver T. 2007 Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev. Biol. 305, 695-713. (doi:10.1016/j.ydbio.2007.02.036)
28. Guantes R, Poyatos JF. 2008 Multistable decision switches for flexible control of epigenetic differentiation. PLoS Comput. Biol. 4, e1000235. (doi:10.1371/journal.pcbi.1000235)
29. Lu M, Jolly MK, Gomoto R, Huang B, Onuchic J, Ben-Jacob E. 2013 Tristability in cancer-associated microRNA-TF chimera toggle switch. J. Phys. Chem. B 117, 13 164-13 174. (doi:10.1021/jp403156m)
30. Hafner M, Max KEA, Bandaru P, Morozov P, Gerstberger S, Brown M, Molina H, Tuschl T. 2013 Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA 19, 613-626. (doi:10.1261/rna.036491.112)
31. Wilbert ML et al. 2012 LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol. Cell 48, 195-206. (doi:10.1016/j.molcel.2012.08.004)
32. Zisoulis DG, Kai ZS, Chang RK, Pasquinelli AE. 2012 Autoregulation of microRNA biogenesis by let-7 and argonaute. Nature 486, 541-544. (doi:10.1038/nature11134)
33. Dhooge A, Govaerts W, Kuznetsov YA. 2003 MATCONT: a Matlab package for numerical bifurcation analysis of ODEs. ACM Trans. Math. Softw. 29, 141-164. (doi:10.1145/779359.779362)
34. Leroy P, Mostov KE. 2007 Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell 18, 1943-1952. (doi:10.1091/mbc.E06-09-0823)
35. Li R et al. 2010 A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51-63. (doi:10.1016/j.stem.2010.04.014)
36. Guo L et al. 2013 Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 32, 5272-5282. (doi:10.1038/onc.2012.573)
37. Penn LJ, Brooks MW, Laufer EM, Land H. 1990 Negative autoregulation of c-myc transcription. EMBO J. 9, 1113-1121.
38. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. 2005 Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167, 59-69. (doi:10.1016/S0002-9440(10)62953-7)
39. Hayot F, Jayaprakash C. 2006 NF-κB oscillations and cell-to-cell variability. J. Theor. Biol. 240, 583-591. (doi:10.1016/j.jtbi.2005.10.018)
40. Wang L, Wu X, Shi T, Lu L. 2013 EGF-induced corneal epithelial wound healing though NF-κB subtype-regulated CTCF activation. J. Biol. Chem. 288, 24 363-24 371. (doi:10.1074/jbc.M113.458141)
41. Conigliaro A et al. 2013 Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ. 20, 1116-1123. (doi:10.1038/cdd.2013.49)
42. Choi SS, Diehl AM. 2009 Epithelial-to-mesenchymal transitions in the liver. Hepatology 50, 2007-2013. (doi:10.1002/hep.23196)
43. Abell AN et al. 2011 MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell 8, 525-537. (doi:10.1016/j.stem.2011.03.008)
44. Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C. 2013 Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PLoS ONE 8, e60315. (doi:10.1371/journal.pone.0060315)
45. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. 2006 NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26, 711-724. (doi:10.1038/sj.onc.1209808)
46. Yamaguchi N et al. 2009 Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100, 1668-1674. (doi:10.1111/j.1349-7006.2009.01228.x)
47. Pattabiraman DR, Weinberg RA. 2014 Tackling the cancer stem cells: what challenges do they pose?Nat. Rev. Drug Discov. 13, 497-512. (doi:10.1038/nrd4253)
48. Aceto N et al. 2014 Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110-1122. (doi:10.1016/j.cell.2014.07.013)
49. Ombrato L, Malanchi I. 2014 The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit. Rev. Oncog. 19, 349-361. (doi:10.1615/CritRevOncog.2014011802)
50. Swetha G, Chandra V, Phadnis S, Bhonde R. 2011 Glomerular parietal epithelial cells of adult murine kidney undergo EMT to generate cells with traits of renal progenitors. J. Cell. Mol. Med. 15, 396-413. (doi:10.1111/j.1582-4934.2009.00937.x)
51. Yovchev MI, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD. 2007 Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 47, 636-647. (doi:10.1002/hep.22047)
52. Strauss R et al. 2011 Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS ONE 6, e16186. (doi:10.1371/journal.pone.0016186)
53. Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM. 2012 Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30, 292-303. (doi:10.1002/stem.791)
54. Liu S et al. 2014 Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2, 78-91. (doi:10.1016/j.stemcr.2013.11.009)
55. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE, Mackenzie IC. 2011 Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 71, 5317-5326. (doi:10.1158/0008-5472.CAN-11-1059)
56. Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S, Knowles BB, Knoepfler PS. 2010 myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 80, 9-19. (doi:10.1016/j.diff.2010.05.001)
57. Lu M, Jolly MK, Onuchic J, Ben-Jacob E. 2014 Toward decoding the principles of cancer metastasis circuits. Cancer Res. 74, 4574-4587. (doi:10.1158/0008-5472.CAN-13-3367)
58. Pinto CA, Widodo E, Waltham M, Thompson EW. 2013 Breast cancer stem cells and epithelial mesenchymal plasticity: implications for chemoresistance. Cancer Lett. 341, 56-62. (doi:10.1016/j.canlet.2013.06.003)
59. Antoniou A, Hébrant A, Dom G, Dumont JE, Maenhaut C. 2013 Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? Cell Cycle 12, 3743-3748. (doi:10.4161/cc.27305)
60. Huang B, Lu M, Jolly MK, Tsarfaty I, Onuchic J, Ben-Jacob E. 2014 The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci. Rep. 4, 6449. (doi:10.1038/srep06449)
61. Roca H et al. 2013 Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS ONE 8, e76773. (doi:10.1371/journal.pone.0076773)